Armistice Capital, LLC X4 Pharmaceuticals, Inc Transaction History

Armistice Capital, LLC

  • $6.02 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
SELL
$0.61 - $0.99 $256,200 - $415,800
-420,000 Reduced 17.83%
1,936,000 $1.63 Million
Q3 2023

Nov 14, 2023
SELL
$1.03 - $2.02 $638,600 - $1.25 Million
-620,000 Reduced 20.83%
2,356,000 $2.57 Million
Q2 2023

Aug 14, 2023
BUY
$0.82 - $2.49 $2.44 Million - $7.41 Million
2,976,000 New
2,976,000 $5.77 Million

Others Institutions Holding XFOR

# of Institutions
105
Shares Held
100M
Call Options Held
213K
Put Options Held
50.6K
View Full List

About X4 Pharmaceuticals, Inc

XFOR Quotes by TradingView
  • Ticker XFOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,646,096
  • Market Cap $23.3M
  • Description
  • X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...
More about XFOR
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email